logo
  

Match Group Withdraws Call For Temporary Restraining Order Against Google

Match Group, Inc. (MTCH) announced Friday it has withdrawn its request for a temporary restraining order against Google, after Google made various concessions that Match Group demanded to benefit consumers.

Those include guaranteeing that Match Group apps will still be allowed to offer users choice in payment systems, lessening the undue burden on developers by its previously stated policy, and eliminating Google's complete control over user data.

In exchange for withdrawing the temporary restraining order, Google has conceded not to force mandatory use of Google Play Billing, not to remove Match Group apps that offer alternate billing systems from Google Play Store, and not gain unfettered access to consumer data and behavior.

As part of this arrangement, Match Group plans to put up to $40 million into an escrow account, instead of paying Google directly for billing transactions that occur on Android outside of Google Play Billing.

Both Match Group and Google can terminate this agreement, but Match Group retains the option to reinstate its request for a temporary restraining order if that should happen. The date for the trial is currently set for April 2023.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
RELATED NEWS
Follow RTT